UKK-0018

· Ukko Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UKK-0018, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies [Phase 1, Phase 2]